Ad is loading...
TMVAX
Price
$30.26
Change
-$0.21 (-0.69%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

TMVAX vs VISVX

Header iconTMVAX vs VISVX Comparison
Open Charts TMVAX vs VISVXBanner chart's image
RBC Microcap Value A
Price$30.26
Change-$0.21 (-0.69%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
TMVAX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TMVAX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TMVAX is a Buy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. TMVAX (121M). VISVX pays higher dividends than TMVAX: VISVX (1.90) vs TMVAX (0.85). TMVAX was incepted earlier than VISVX: TMVAX (21 years) vs VISVX (27 years). TMVAX is a more actively managed with annual turnover of: 30.00 vs. VISVX (16.00). TMVAX has a lower initial minimum investment than VISVX: TMVAX (1000) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : 28.71 vs. TMVAX (17.84). VISVX return over 5 years is better than : 57.32 vs. TMVAX (15.31).
TMVAXVISVXTMVAX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years27 years-
Gain YTD13.07915.43385%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets121M57.6B0%
Annual Yield % from dividends0.851.9045%
Returns for 1 year17.8428.7162%
Returns for 3 years-12.7813.23-97%
Returns for 5 years15.3157.3227%
Returns for 10 years13.21108.2112%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics